Gemcitabine induced radiation recall myositis: Report of two cases

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi

Volumn 19, Issue 4, 2009, Pages 249-253

  Alco, Gül ^a   Igdem, Sefik ^b   Dincer, Maktav ^a   Tecimer, Coşkun ^b   Senturk, Rana ^c   Vural, Metin ^d   Okkan, Sait ^b  

^a Department of Radiation Oncology   (Turkey)

^b ISTANBUL BILIM UNIVERSITY   (Turkey)

^c Florence Nightingale Gayrettepe Hospital   (Turkey)

^d AMERICAN HOSPITAL   (Turkey)

Author keywords

Gemcitabine; Myositis; Radiation recall; Side effect

Indexed keywords

ALPHA TOCOPHEROL; CARBOPLATIN; CORTICOSTEROID; FLUOROURACIL; GABAPENTIN; GEMCITABINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; SELENIUM; SUPEROXIDE DISMUTASE;

ADJUVANT THERAPY; ADULT; AGED; ANAMNESIS; ARTHRALGIA; ARTICLE; CANCER INVASION; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MULTIPLE CYCLE TREATMENT; MYALGIA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PANCREAS CARCINOMA; RADIATION RECALL MYOSITIS; RADIATION SICKNESS; TUMOR VOLUME;

EID: 74049152487     PISSN: 1306133X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. D'Angio GJ, Farber S, Maddock CL. Potentiation of x-ray effects by actinomycin-D. Radiology 73: 175-177, 1959.
2. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59: 237-245, 2001.
3. Azria D, Magné N, Zouhair A et al. Radiation recall: A well recognized but neglected phenomenon. Can Treat Rev 31: 555-570, 2005.
4. Friedlander PA, Bansal R, Schwartz L et al. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 100: 1793-1799, 2004.
5. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13: 227-236, 1990.
6. Jeter MD, Jänne PA, Brooks S et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 53: 394-400, 2002.
7. Schwarte S, Wagner K, Kartens JH, Bremer M. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol 183: 215-217, 2007.
8. Welsh JS, Torre TG, DeWeese TL, O'Reilly S. Radiation myositis. Ann Oncol 10: 1105-1108, 1999.
9. Fogarty G, Ball D, Rischin D. Radiation recall reaction following gemcitabine, Lung Cancer 33: 299-302, 2001.
10. Miura G, Matsumoto T, Tanaka N, et al. Two cases of radiation myositis probably induced by recall phenomenon. Nippon Igaku Hoshasen Gakkai Zasshi. 63: 420-422, 2003.
11. Horan G, Smith SL, Podd TJ. Gemcitabine-induced radiation necrosis of pectoralis major muscle. Clin Oncol 18: 85, 2006.
12. Squire S, Chan M, Feller E, et al. An unusual case of gemcitabine-induced radiation recall. Am J Clin Oncol 29: 636, 2006.
13. Ganem G, Solal-Celigny P, Joffroy A, et al. Radiation myositis: The possible role of gemcitabine. Ann Oncol 11:1615-1616, 2000.
14. Pinson PJ, Griep C, Sanders WH, Lelie B. Myositis as a "radiatior-recall phenomenon" following palliative chemotherapy with carboplatin-gemcitabin for non-small cell polmonary carcinoma. Ned Tijdschr Geneeskd 150: 1891-1894, 2006.
15. Fakih MG. Gemcitabine-induced rectus abdominis radiation recall. J Pancreas 7: 306-310, 2006.
16. Moulder JE. Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Semin Radiat Oncol 13: 73-84, 2003.
17. Cohn GH, Hyperbaric oxygen therapy. Promoting healing in difficult cases. Postgrad Med 79: 89-92, 1986.
18. Bentzen SM, Overgaard M, Thames HD. Fractionation sensitivity of a functional endpoint: Impaired shoulder movement after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 17: 531-7, 1989.